PRKCZ and breast cancer: In contrast to our findings that untransformed MECs use Rictor to activate PKC-alpha and Rac1-mediated invasion, breast cancer cells used Rictor to drive motility through protein kinase C-zeta (PKC-zeta; [18]), integrin-linked kinase (ILK; [52]) and Akt [49].